Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02259231
Title RTA 408 Capsules in Patients With Melanoma - REVEAL
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Reata Pharmaceuticals, Inc.
Indications

melanoma

Therapies

Ipilimumab

Nivolumab

Omaveloxolone

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Southern Cancer Center Mobile Alabama 36608 United States Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora Colorado 80045 United States Details
Christiana Hospital Helen F. Graham Cancer Center Newark Delaware 19713 United States Details
Goergetown-Lombardi Comprehensive Cancer Center Washington District of Columbia 20007 United States Details
H. Lee Moffitt Cancer Center & Research Institute Tampa Florida 33612 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Atlantic Melanoma Center Morristown New Jersey 07960 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field